These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 24165020)

  • 1. The role of androgen receptor CAG repeat polymorphism and other factors which affect the clinical response to testosterone replacement in metabolic syndrome and type 2 diabetes: TIMES2 sub-study.
    Stanworth RD; Akhtar S; Channer KS; Jones TH
    Eur J Endocrinol; 2014 Feb; 170(2):193-200. PubMed ID: 24165020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen receptor gene CAG repeat polymorphism independently influences recovery of male sexual function after testosterone replacement therapy in postsurgical hypogonadotropic hypogonadism.
    Tirabassi G; Delli Muti N; Corona G; Maggi M; Balercia G
    J Sex Med; 2014 May; 11(5):1302-8. PubMed ID: 24593124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen receptor CAG repeat polymorphism is associated with serum testosterone levels, obesity and serum leptin in men with type 2 diabetes.
    Stanworth RD; Kapoor D; Channer KS; Jones TH
    Eur J Endocrinol; 2008 Dec; 159(6):739-46. PubMed ID: 18805913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central body fat changes in men affected by post-surgical hypogonadotropic hypogonadism undergoing testosterone replacement therapy are modulated by androgen receptor CAG polymorphism.
    Tirabassi G; delli Muti N; Buldreghini E; Lenzi A; Balercia G
    Nutr Metab Cardiovasc Dis; 2014 Aug; 24(8):908-13. PubMed ID: 24787905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of androgen receptor CAG polymorphism on sexual function recovery after testosterone therapy in late-onset hypogonadism.
    Tirabassi G; Corona G; Biagioli A; Buldreghini E; delli Muti N; Maggi M; Balercia G
    J Sex Med; 2015 Feb; 12(2):381-8. PubMed ID: 25443437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of testosterone replacement therapy on bone metabolism in male post-surgical hypogonadotropic hypogonadism: focus on the role of androgen receptor CAG polymorphism.
    Tirabassi G; delli Muti N; Gioia A; Biagioli A; Lenzi A; Balercia G
    J Endocrinol Invest; 2014 Apr; 37(4):393-400. PubMed ID: 24458833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CAG repeat polymorphism in androgen receptor gene is not directly associated with polycystic ovary syndrome but influences serum testosterone levels.
    Skrgatic L; Baldani DP; Cerne JZ; Ferk P; Gersak K
    J Steroid Biochem Mol Biol; 2012 Feb; 128(3-5):107-12. PubMed ID: 22107839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen receptor gene CAG repeat length and body mass index modulate the safety of long-term intramuscular testosterone undecanoate therapy in hypogonadal men.
    Zitzmann M; Nieschlag E
    J Clin Endocrinol Metab; 2007 Oct; 92(10):3844-53. PubMed ID: 17635942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dyslipidaemia is associated with testosterone, oestradiol and androgen receptor CAG repeat polymorphism in men with type 2 diabetes.
    Stanworth RD; Kapoor D; Channer KS; Jones TH
    Clin Endocrinol (Oxf); 2011 May; 74(5):624-30. PubMed ID: 21470285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CAG repeat testing of androgen receptor polymorphism: is this necessary for the best clinical management of hypogonadism?
    Francomano D; Greco EA; Lenzi A; Aversa A
    J Sex Med; 2013 Oct; 10(10):2373-81. PubMed ID: 23844628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study).
    Jones TH; Arver S; Behre HM; Buvat J; Meuleman E; Moncada I; Morales AM; Volterrani M; Yellowlees A; Howell JD; Channer KS;
    Diabetes Care; 2011 Apr; 34(4):828-37. PubMed ID: 21386088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible role of
    Firouzi V; Borjian Boroujeni P; Rokhsat Talab Z; Mohammadi M; Sadighi Gilani MA; Sabbaghian M; Mohseni Meybodi A
    Syst Biol Reprod Med; 2019 Aug; 65(4):326-332. PubMed ID: 31030566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetics of testosterone replacement therapy.
    Zitzmann M
    Pharmacogenomics; 2009 Aug; 10(8):1341-9. PubMed ID: 19663677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate volume and growth in testosterone-substituted hypogonadal men are dependent on the CAG repeat polymorphism of the androgen receptor gene: a longitudinal pharmacogenetic study.
    Zitzmann M; Depenbusch M; Gromoll J; Nieschlag E
    J Clin Endocrinol Metab; 2003 May; 88(5):2049-54. PubMed ID: 12727953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The androgen receptor CAG repeat modifies the impact of testosterone on insulin resistance in women with polycystic ovary syndrome.
    Möhlig M; Jürgens A; Spranger J; Hoffmann K; Weickert MO; Schlösser HW; Schill T; Brabant G; Schüring A; Pfeiffer AF; Gromoll J; Schöfl C
    Eur J Endocrinol; 2006 Jul; 155(1):127-30. PubMed ID: 16793958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen receptor CAG repeat polymorphism is not associated with insulin resistance and diabetes among South Asian males.
    Malavige LS; Jayawickrama S; Ranasinghe P; Levy JC
    BMC Res Notes; 2017 Dec; 10(1):685. PubMed ID: 29202793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between androgen receptor gene CAG repeat polymorphism and plasma testosterone levels in postmenopausal women.
    Brum IS; Spritzer PM; Paris F; Maturana MA; Audran F; Sultan C
    J Soc Gynecol Investig; 2005 Feb; 12(2):135-41. PubMed ID: 15695110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone mass in subjects with Klinefelter syndrome: role of testosterone levels and androgen receptor gene CAG polymorphism.
    Ferlin A; Schipilliti M; Vinanzi C; Garolla A; Di Mambro A; Selice R; Lenzi A; Foresta C
    J Clin Endocrinol Metab; 2011 Apr; 96(4):E739-45. PubMed ID: 21270324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased estrogen rather than decreased androgen action is associated with longer androgen receptor CAG repeats.
    Huhtaniemi IT; Pye SR; Limer KL; Thomson W; O'Neill TW; Platt H; Payne D; John SL; Jiang M; Boonen S; Borghs H; Vanderschueren D; Adams JE; Ward KA; Bartfai G; Casanueva F; Finn JD; Forti G; Giwercman A; Han TS; Kula K; Lean ME; Pendleton N; Punab M; Silman AJ; Wu FC;
    J Clin Endocrinol Metab; 2009 Jan; 94(1):277-84. PubMed ID: 18840639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of androgen receptor CAG repeat polymorphism on andropausal symptoms in different serum testosterone levels.
    Liu CC; Lee YC; Wang CJ; Yeh HC; Li WM; Wu WJ; Huang CN; Bao BY; Huang CH; Huang SP
    J Sex Med; 2012 Sep; 9(9):2429-37. PubMed ID: 22429282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.